Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0002061851-26-000002

Options or other derivatives

  • Chief Legal Officer acquired 103,140 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fitzpatrick Jennifer · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +103,140 103,140 D
Loading xslF345X05/edgardoc.xml…